Register to receive a free Europe Market for Interventional Cardiology Devices report synopsis and brochure
According to a new report on the Europe market for interventional cardiology by iData Research (www.idataresearch.com), drug-eluting stents accounted for a significant portion of the European markets for interventional cardiology devices in 2014. The advent of drug-eluting stents has driven the interventional cardiology market beyond expectations, as these devices have managed to increase the size of the market by virtue of their relatively high average selling price (ASP). New developments in drug-eluting stents such as biodegradable materials are expected to keep the market competitive despite safety concerns regarding late stent thrombosis.
In 2014, the European markets for interventional cardiology were valued at nearly EUR 1.3 billion, a nearly 10% decrease from the previous year. The total European market for interventional cardiology devices is projected to decline as a result of continued decline in average selling prices due to the competitive tender systems being adopted across Europe, low procedure numbers and a decrease in devices used per procedure due to improvements in medical devices and cardiologist best practices.
“Unit sales growth is expected to be driven by a new generation of drug-eluting stents, which are expected to alleviate physician concerns over thrombosis issues, as well as decreased ASPs which may trigger physicians to stent more,” explains Dr. Kamran Zamanian, CEO of iData.
The negative growth experienced throughout many countries over 2011 and 2012 was due primarily to turbulent macroeconomic conditions throughout the European region. The U.K. showed the largest decline due to the entrance of substantially lower priced products being brought into the country from Germany. Benelux and Spain are also expected to see large market declines due to prevalent price erosion and the lackluster unit sales growth in their respective markets. Spending cuts throughout many countries and uncertainty regarding default were major contributors to the stifling of growth of many markets. Austria is expected to be the only country to experience growth due to its premium pricing system modelled after the Swiss market and its proximity to the leading German market.
Abbott Laboratories has been the leading competitor in the drug-eluting stent (DES) market with over 30% market share. Their actual selling price for DES has been quite low due to competition with Boston Scientific. Other competitors include Medtronic, Biotronik, B. Braun, Biosensors International, Cornova, and Disa Vascular among others.
For Further Information
More on the drug-eluting stent market in Europe can be found in the report published by iData entitled Europe Market for Interventional Cardiology. This report covers drug-eluting stents, bare-metal stents, bioabsorbable stents, PTCA balloons, drug-eluting balloons, interventional catheters and guidewires, diagnostic catheters and guidewires, coronary introducer sheaths, embolic protection devices, atherectomy devices, intravascular ultrasound (IVUS) catheters and optical coherence tomography (OCT) catheters.
The iData series on the market for interventional cardiology devices covers the U.S., Asian Pacific, Brazil, and 15 countries in Europe encompassing Germany, France, the United Kingdom (U.K.), Italy, Spain, Benelux (Belgium, Netherlands and Luxemburg), Scandinavia (Finland, Denmark, Sweden and Norway), Portugal, Austria and Switzerland. Full reports also provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment.
To find out more about European interventional cardiology market data or procedure data, register online or email us at [email protected] for a Europe Market for Interventional Cardiology report brochure and synopsis.
Explore our careers page for our current available job opportunities. This is your chance to join a fun and dynamic team in the medical market research industry. Send your resume to [email protected] with the job title in the subject line, and feel free to tell us a little about yourself. We look forward to hearing from you.